9α,11β-PGF2 (9α,11β-Prostaglandin F2), a prostaglandin metabolite that is enzymatically formed in the liver, lung, and kidneys, has been reported to cause constriction of canine coronary artery strips and inhibit platelet aggregation. Additional experiments have shown that this compound is also a potent bronchoconstrictor agent of human airways and isolated guinea pig trachea|in vitro|. Other studies have noted that 9α,11β-Prostaglandin F2 demonstrates the ability to be a potent adipose differentiation inhibitor which causes adipocyte tissue growth interference.
